Search research articles
Contact Us
Filters
Showing results (81-90 of 142) with videos related to
Page
of 15
Sort By:
Allergy, Asthma & Immunology Research
|
September 16, 2020
Chitinase 3-Like 1 Contributes to Food Allergy via M2 Macrophage Polarization
Eun Gyul Kim, Mi Na Kim, Jung Yeon Hong, et al.
The Journal of Clinical Investigation
|
May 4, 2006
Adenosine metabolism and murine strain-specific IL-4-induced inflammation, emphysema, and fibrosis
Bing Ma, Michael R Blackburn, Chun Geun Lee, et al.
Translational Oncology
|
August 23, 2024
Chitinase 3-like-1 (CHI3L1) in the pathogenesis of epidermal growth factor receptor mutant non-small cell lung cancer
Suchitra Kamle, Bing Ma, Gail Schor, et al.
Hepatology (Baltimore, Md.)
|
December 19, 2017
Chitinase 3-like-1 promotes intrahepatic activation of coagulation through induction of tissue factor in mice
Zhao Shan, Xiaodong Liu, Yuan Chen, et al.
American Journal of Respiratory Cell and Molecular Biology
|
July 27, 2010
Role of breast regression protein-39 in the pathogenesis of cigarette smoke-induced inflammation and emphysema
Hiroshi Matsuura, Dominik Hartl, Min-Jong Kang, et al.
American Journal of Respiratory and Critical Care Medicine
|
December 25, 2008
Genetic variation in the promoter region of chitinase 3-like 1 is associated with atopy
Myung Hyun Sohn, Ji Hyun Lee, Kyung Won Kim, et al.
JCI Insight
|
September 21, 2018
Laminin α1 is a genetic modifier of TGF-β1-stimulated pulmonary fibrosis
Chang-Min Lee, Soo Jung Cho, Won-Kyung Cho, et al.
The Journal of Biological Chemistry
|
October 23, 2012
Amphiregulin, an epidermal growth factor receptor ligand, plays an essential role in the pathogenesis of transforming growth factor-β-induced pulmonary fibrosis
Yang Zhou, Jae-Young Lee, Chang-Min Lee, et al.
American Journal of Respiratory Cell and Molecular Biology
|
June 9, 2022
Kasugamycin Is a Novel Chitinase 1 Inhibitor with Strong Antifibrotic Effects on Pulmonary Fibrosis
Jae-Hyun Lee, Chang-Min Lee, Joyce H Lee, et al.
Pharmaceutics
|
May 27, 2026
Targeting Lysyl Oxidase-like 2: A Therapeutic Strategy for Idiopathic Pulmonary Fibrosis with a Novel Indolizine Derivative
Doo Hee Shim, Min Jung Kim, Hyeon Woo Chung, et al.
Page
of 15
Search research articles
Search
Showing results (81-90 of 142) with videos related to
Sort By:
Page
of 15
Allergy, Asthma & Immunology Research
|
September 16, 2020
Chitinase 3-Like 1 Contributes to Food Allergy via M2 Macrophage Polarization
Eun Gyul Kim, Mi Na Kim, Jung Yeon Hong, et al.
The Journal of Clinical Investigation
|
May 4, 2006
Adenosine metabolism and murine strain-specific IL-4-induced inflammation, emphysema, and fibrosis
Bing Ma, Michael R Blackburn, Chun Geun Lee, et al.
Translational Oncology
|
August 23, 2024
Chitinase 3-like-1 (CHI3L1) in the pathogenesis of epidermal growth factor receptor mutant non-small cell lung cancer
Suchitra Kamle, Bing Ma, Gail Schor, et al.
Hepatology (Baltimore, Md.)
|
December 19, 2017
Chitinase 3-like-1 promotes intrahepatic activation of coagulation through induction of tissue factor in mice
Zhao Shan, Xiaodong Liu, Yuan Chen, et al.
American Journal of Respiratory Cell and Molecular Biology
|
July 27, 2010
Role of breast regression protein-39 in the pathogenesis of cigarette smoke-induced inflammation and emphysema
Hiroshi Matsuura, Dominik Hartl, Min-Jong Kang, et al.
American Journal of Respiratory and Critical Care Medicine
|
December 25, 2008
Genetic variation in the promoter region of chitinase 3-like 1 is associated with atopy
Myung Hyun Sohn, Ji Hyun Lee, Kyung Won Kim, et al.
JCI Insight
|
September 21, 2018
Laminin α1 is a genetic modifier of TGF-β1-stimulated pulmonary fibrosis
Chang-Min Lee, Soo Jung Cho, Won-Kyung Cho, et al.
The Journal of Biological Chemistry
|
October 23, 2012
Amphiregulin, an epidermal growth factor receptor ligand, plays an essential role in the pathogenesis of transforming growth factor-β-induced pulmonary fibrosis
Yang Zhou, Jae-Young Lee, Chang-Min Lee, et al.
American Journal of Respiratory Cell and Molecular Biology
|
June 9, 2022
Kasugamycin Is a Novel Chitinase 1 Inhibitor with Strong Antifibrotic Effects on Pulmonary Fibrosis
Jae-Hyun Lee, Chang-Min Lee, Joyce H Lee, et al.
Pharmaceutics
|
May 27, 2026
Targeting Lysyl Oxidase-like 2: A Therapeutic Strategy for Idiopathic Pulmonary Fibrosis with a Novel Indolizine Derivative
Doo Hee Shim, Min Jung Kim, Hyeon Woo Chung, et al.
Page
of 15